found to be unstable and so was used without purification. dH (400
MHz, CDCl3) 1.83–1.97 (2H, m, 1¢-H2), 2.68 (2H, td, J 8.0, 1.6
Hz, 2¢-H2), 2.91–2.95 (2H, m, 3-H2), 4.07–4.14 (1H, m, 6-H), 5.69–
5.74 (1H, m, 5-H), 5.80 (1H, dtd, J 10.4, 3.2, 1.6 Hz, 4-H), 6.72
(1H, br s, NH), 7.16–7.33 (5H, m, Ph). To a solution of (6R)-6-
phenethyl-3,6-dihydro-1H-pyridin-2-one (29) (0.11 g, 0.55 mmol)
in ethyl acetate (35 mL) was added 10% palladium on carbon
(0.04 g, 0.04 mmol wrt Pd). The solution was purged with hydrogen
gas for 0.25 h then stirred under an atmosphere of hydrogen at
room temperature for 18 h. The reaction mixture was filtered
ganic layer was dried (MgSO4), filtered and concentrated in vacuo.
Flash column chromatography (petroleum ether/diethyl ether
85 : 15) afforded (6R)-N-(tert-butoxycarbonyl)-6-propylpiperidine
(33) (0.034 g, 48%) as a colourless oil. [a]2D4 -25.6 (c 0.6, CHCl3),
lit.18 [a]2D3 -31.6 (c 0.9, CHCl3); dH (400 MHz, CDCl3) 0.85 (3H,
t, J 7.2 Hz, 3¢-H3), 1.14–1.32 (4H, m, 1¢-H2 and 2¢-H2), 1.38 (9H,
s, OtBu), 1.41–1.63 (6H, m, 3-H2, 4-H2 and 5-H2), 2.67 (1H, td, J
13.6, 2.6 Hz, 6-HH), 3.89 (1H, br d, J 2.6 Hz, 6-HH), 4.14 (1H, br
s, 2-H); dC (100 MHz, CDCl3) 14.1 (CH3), 19.1 (2 ¥ CH2), 19.5 (2 ¥
CH2), 25.7 (CH2), 28.5 (3 ¥ CH3), 31.9 (CH2), 50.1 (CH), 17.9 (C),
155.2 (C); m/z (EI) 227 (M+, 4%), 184 (18), 149 (17), 128 (100).
R
through Celiteꢀ and washed with ethyl acetate (30 mL). The filtrate
was concentrated under reduced pressure to yield a white solid.
Flash column chromatography (dichloromethane/methanol 1 : 0
to 96 : 4) gave (6S)-6-phenethylpiperidin-2-one (0.11 g, 100%) as
a white solid. Mp 84–86 ◦C; nmax/cm-1 (neat) 3214 (NH), 2942
(CH), 1651 (CO), 1603 (C C), 1402, 1343, 1090; [a]2D2 +5.0 (c
1.4, CHCl3); dH (400 MHz, CDCl3) 1.37–1.47 (1H, m, 5-HH),
1.63–1.75 (1H, m, 5-HH), 1.78–1.84 (2H, m, 1¢-H2), 1.86–1.98
(2H, m, 4-H2), 2.30 (1H, ddd, J 16.4, 10.4, 6.0 Hz, 3-HH), 2.35–
2.44 (1H, m, 3-HH), 2.67 (2H, td, J 7.6, 2.8 Hz, 2¢-H2), 3.36–3.42
(1H, m, 6-H), 6.03 (1H, br s, NH), 7.16–7.31 (5H, m, Ph); dC (100
MHz, CDCl3) 19.7 (CH2), 28.4 (CH2), 31.4 (CH2), 31.6 (CH2), 38.6
(CH2), 52.6 (CH2), 126.2 (CH), 128.3 (2 ¥ CH), 128.6 (2 ¥ CH),
140.9 (C), 172.4 (C); m/z (EI) 203.1313 (M+. C13H17NO requires
203.1310), 186 (5%), 125 (27), 112 (66), 98 (100).
Acknowledgements
The authors are grateful to the EPSRC (studentship to M.D.),
GlaxoSmithKline and the University of Glasgow for financial
support.
Notes and references
1 For some recent general reviews see: (a) P. M. Weintraub, J. S. Sabol, J.
M. Kane and D. R. Borcherding, Tetrahedron, 2003, 59, 2953; (b) M. G.
P. Buffat, Tetrahedron, 2004, 60, 1701; (c) A. Deiters and S. F. Martin,
Chem. Rev., 2004, 104, 2199; (d) J. P. A. Harrity and O. Provoost, Org.
Biomol. Chem., 2005, 3, 1349; (e) S. F. Kirsch, Synthesis, 2008, 3183;
(f) S. Kotha, M. Meshram and A. Tiwari, Chem. Soc. Rev., 2009, 38,
2065; (g) E. G. Occhiato, D. Scarpi and C. Prandi, Heterocycles, 2010,
80, 697.
2 For the synthesis of 1H-pyrrol-2(5H)-ones see: (a) Y. Ohfune and M.
Tomita, J. Am. Chem. Soc., 1982, 104, 3511; (b) J. Ackermann, M.
Matthes and C. Tamm, Helv. Chim. Acta, 1990, 73, 122; (c) N. Langlois,
N. Van Bac, N. Dahuron, J.-M. Delcroix, A. Deyine, D. Griffart-
Brunet, A. Chiaroni and C. Riche, Tetrahedron, 1995, 51, 3571; (d) M.
G. B. Drew, R. J. Harrison, J. Mann, A. J. Tench and R. J. Young,
Tetrahedron, 1999, 55, 1163; (e) A. G. M. Barret, J. Head, M. L. Smith,
N. S. Stock, A. J. P. White and D. J. Williams, J. Org. Chem., 1999,
64, 6005; (f) P. J. Dransfield, S. Wang, A. Dilley and D. Romo, Org.
Lett., 2005, 7, 1679; (g) S. Roy and C. Spino, Org. Lett., 2006, 8, 939;
(h) O. Ahmed, P. B. Hitchcock and D. W. Young, Org. Biomol. Chem.,
2006, 4, 1596; (i) J. F. Bower, S. Chakthong, J. Svenda, A. J. Williams,
R. M. Lawrence, P. Szeto and T. Gallagher, Org. Biomol. Chem., 2006,
4, 1868; (j) A. Gheorghem, M. Schulte and O. Reiser, J. Org. Chem.,
2006, 71, 2173; (k) C. Spino, L. Boisvert, J. Douville, S. Roy, S. Lauzon,
J. Minville, D. Gagnon, F. Beaumier and C. Chabot, J. Organomet.
Chem., 2006, 691, 5336; (l) S. Spiess, C. Berthold, R. Weihofen and G.
Helmchen, Org. Biomol. Chem., 2007, 5, 2357; (m) C. Curti, A. Sartori,
L. Battistini, G. Rassu, P. Burreddu, F. Zanardi and G. Casiraghi, J.
Org. Chem., 2008, 73, 5446; (n) G. B. Bajracharya, P. S. Koranne, R. N.
Nadaf, R. Kassem, M. Gabr, K. Takenaka, S. Takizawa and H. Sasai,
Chem. Commun., 2010, 46, 9064.
3 For the synthesis of 3,6-dihydro-1H-pyridin-2-ones see: (a) V. K.
Aggarwal, E. Alonso, G. Fang, M. Ferrara, G. Hynd and M. Porcelloni,
Angew. Chem., Int. Ed., 2001, 40, 1433; (b) J. G. Knight, I. M. Lawson
and C. N. Johnson, Synthesis, 2006, 227; (c) A. Niida, M. Mizumoto,
T. Narumi, E. Inokuchi, S. Oishi, H. Ohno, A. Otaka, K. Kitaura and
N. Fujii, J. Org. Chem., 2006, 71, 4118; (d) G. Calvet, N. Blanchard
and C. Kouklovsky, Org. Lett., 2007, 9, 1485; (e) A. G. Jamieson and
A. Sutherland, Org. Lett., 2007, 9, 1609; (f) J. H. Lee, S. Shin, J. Kang
and S. Lee, J. Org. Chem., 2007, 72, 7443; (g) S. Lauzon, F. Tremblay,
D. Gagnon, C. Godbout, C. Chabot, C. Mercier-Shanks, S. Perreault,
H. DeSe`ve and C. Spino, J. Org. Chem., 2008, 73, 6239; (h) H. Nomura
and C. J. Richards, Org. Lett., 2009, 11, 2892.
(6R)-6-Propylpiperidin-2-one (32)3h
The hydrogenation reaction was carried out as described above
using (6R)-6-propyl-3,6-dihydro-1H-pyridin-2-one (31) (0.07 g,
0.52 mmol). This gave (6R)-6-propylpiperidin-2-one (32) (0.07 g,
100%) as a white solid. Spectroscopic data consistent with
literature.3h Mp 73–76 ◦C; nmax/cm-1 (neat) 2960 (CH), 2360, 1653
(CO), 1410, 1215, 747; [a]2D5 -18.1 (c 1.3, CHCl3); dH (400 MHz,
CDCl3) 0.87 (3H, t, J 7.2 Hz, 3¢-H3), 1.21–1.41 (5H, m, 1¢-HH, 2¢-
H2 and 4-H2), 1.56–1.66 (1H, m, 5-HH), 1.79–1.87 (2H, m, 1¢-HH
and 5-HH), 2.21 (1H, ddd, J 13.6, 8.8, 4.8 Hz, 3-HH), 2.29–2.36
(1H, m, 3-HH), 3.26–3.32 (1H, m, 6-H), 5.76 (1H, br s, NH);
dC (100 MHz, CDCl3) 13.9 (CH3), 18.5 (CH2), 19.8 (CH2), 28.5
(CH2), 31.4 (CH2), 39.1 (CH2), 53.0 (CH), 172.3 (C); m/z (CI)
142.1236 (MH+. C8H16NO requires 142.1232), 113 (26%), 97 (42),
85 (78), 71 (100).
(6R)-N-(tert-Butoxycarbonyl)-6-propylpiperidine (33)18
To a solution of (6R)-6-propylpiperidin-2-one (32) (0.04 g,
0.31 mmol) in diethyl ether (50 mL) was added lithium aluminium
hydride (1.87 mL, 1.87 mmol, 1 M in diethyl ether). The reaction
was heated to 30 ◦C for 18 h. The reaction was quenched with 2 M
potassium hydroxide solution (10 mL) then partitioned between
diethyl ether (20 mL) and water (20 mL). The organic layer was
separated, washed with water (3 ¥ 20 mL), dried (MgSO4), filtered
and concentrated at atmospheric pressure and 40 ◦C. The resulting
residue was dissolved in diethyl ether (20 mL) and di-tert-butyl
dicarbonate (0.27 g, 1.25 mmol), 4-dimethylaminopyridine (0.02 g,
0.13 mmol) and triethylamine (0.18 mL, 1.31 mmol) were added.
The reaction was stirred at room temperature for 18 h, then
washed with 1 M hydrochloric acid (10 mL), saturated sodium
hydrogencarbonate solution (10 mL), and brine (10 mL). The or-
4 (a) F. I. McGonagle, L. Brown, A. Cooke and A. Sutherland, Org.
Biomol. Chem., 2010, 8, 3418; (b) F. I. McGonagle, L. Brown, A. Cooke
and A. Sutherland, Tetrahedron Lett., 2011, 52, 2330.
5 Methyl (2S)-2-hydroxy-3-phenylpropionate (7) can also be easily
prepared in two steps from L-phenylalanine. For example, see: (a) P.
Kock, Y. Nakatani, B. Luu and G. Ourisson, Bull. Soc. Chim. Fr., 1983,
11, 189; (b) W.-R. Li, W. R. Ewing, B. D. Harris and M. M. Joullie´, J.
Am. Chem. Soc., 1990, 112, 7659.
This journal is
The Royal Society of Chemistry 2011
Org. Biomol. Chem., 2011, 9, 6761–6770 | 6769
©